ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Opinion   
  • Int J Inflam Cancer Integr Ther 2024, Vol 11(1): 266

Unraveling the Challenge of Multidrug Resistance in PC-3 Prostate Cancer Therapy

Jitsua Usoda*
Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan
*Corresponding Author : Jitsua Usoda, Department of Biotechnology and Drug Discovery, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan, Email: jitusoda@tokyo-med.ac.jp

Received Date: Feb 05, 2024 / Published Date: Feb 29, 2024

Citation: Usoda J (2024) Unraveling the Challenge of Multidrug Resistance inPC-3 Prostate Cancer Therapy. Int J Inflam Cancer Integr Ther, 11: 266.

Copyright: © 2024 Usoda J. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top